Journal Article Review Epublish
PubMed: 40308594 DOI: 10.3389/fimmu.2025.1564909
Treatments and cancer: implications for radiologists.
Front Immunol 16:1564909
Authors: Vincenza Granata, Roberta Fusco, Sergio Venanzio Setola, Assunta Borzacchiello, Francesca Della Sala, Ivano Rossi, Ludovica Ravo, Domenico Albano, Angelo Vanzulli, Antonella Petrillo, Francesco Izzo
Affiliations
- Division of Radiology, Istituto Nazionale Tumori IRCCS Fondazione Pascale - IRCCS di Napoli, Naples, Italy.
- Institute of Polymers, Composites and Biomaterials, National Research Council (IPCB-CNR), Naples, Italy.
- Division of Radiology, Università degli Studi di Napoli Federico II, Naples, Italy.
- Diagnostic and Interventional Radiology Unit, IRCCS Istituto Ortopedico Galeazzi, Milan, Italy.
- Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche, Università degli Studi di Milano, Milano, Italy.
- Department of Radiology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.
- Department of Oncology and Hemato-Oncology, Università degli Studi di Milano, Milan, Italy.
- Division of Epatobiliary Surgical Oncology, Istituto Nazionale Tumori IRCCS Fondazione Pascale-IRCCS di Napoli, Naples, Italy.
Abstract
This review highlights the critical role of radiologists in personalized cancer treatment, focusing on the evaluation of treatment outcomes using imaging tools like Computed Tomography (CT), Magnetic Resonance Imaging (MRI), and Ultrasound. Radiologists assess the effectiveness and complications of therapies such as chemotherapy, immunotherapy, and ablative treatments. Understanding treatment mechanisms and consistent imaging protocols are essential for accurate evaluation, especially in managing complex cases like liver cancer. Collaboration between radiologists and oncologists is key to optimizing patient outcomes through precise imaging assessments.
MeSH
Radiologists, Neoplasms, Radiology, Liver Neoplasms, Precision Medicine, Therapeutics